Fatal infection risk in newborns may increase when this bacteria and fungus mix
A new study reveals that when Streptococcus agalactiae (GBS) interacts with Candida albicans, GBS is more likely to spread disease and become harder to treat in newborns. Infection by both microbes reduces the effectiveness of existing GBS treatments.
Registered users, subscribers or members - SIGN IN
To continue reading this article
Membership
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
Find out more about how to join.
Register
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
Subscribe
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.